Cognition in Chagas disease: A systematic review
DOI:
https://doi.org/10.33448/rsd-v10i9.17549Keywords:
Cognition; Chagas disease; Executive function; Systematic review; Memory disorders.Abstract
Chagas disease (CD) is transmitted by the hemoflagellate parasite Trypanosoma cruzi and manifests itself acutely and chronically, when it is characterized as indeterminate, cardiac, digestive or mixed. Some patients with Chagas' disease (CD) have cognitive alterations and there are three hypotheses about cognitive damage: (I) neurological and cognitive alterations caused by the cardiac form, (II) after the acute form there is the spontaneous disappearance of the clinical signs of disease with cognitive manifestations remaining, (III) cognitive and neurological manifestations are caused by chronic infection. The aim of the present study was to carry out a systematic review of the literature to verify measurable cognitive impairments in Chagas patients. The articles were searched in the Pubmed and Embase databases, with the descriptors "Chagas disease" and "cognition". All articles with assessment of cognitive aspects of patients with CD were included. One hundred and ninety-seven articles were found, three of which met the criteria. All articles demonstrate cognitive impairments related to CD, in a chronic form, with impairment of both general intelligence and long-term memory, in addition to a deficit in the execution time of the tests.
References
Aras, R., Matta, J. A. M. D., Mota, G., Gomes, I., & Melo, A. (2003). Cerebral infarction in autopsies of chagasic patients with heart failure. Arquivos brasileiros de cardiologia, 81(4), 414-416.
Aronow, W. S. (2005). Drug treatment of systolic and of diastolic heart failure in elderly persons. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60(12), 1597-1605.5.
Barreira, A. A., Said, G., & Krettli, A. U. (1981). Multifocal demyelinative lesions of peripheral nerves in experimental chronic Chagas's disease. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75(5), 751-751.
Carvalho, N. B. (2015). Manual de atendimento a pacientes com doença de Chagas: atenção básica 2014/2015. Faculdade de Medicina USP. São Paulo, 159-218.
Cibis, I. I. (1999). Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS II). Lancet, 353(9), 13.
Carod-Artal, F. J., Vargas, A. P., Horan, T. A., & Nunes, L. G. N. (2005). Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke, 36(5), 965-970.
Chagas, C. (1909). Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Memórias do Instituto Oswaldo Cruz, 1(2), 159-218.
Chagas, C. (1911). Nova entidade morbida do homem: rezumo geral de estudos etiolojicos e clinicos. Memórias do Instituto Oswaldo Cruz, 3(2), 219-275.
Da Saude, M. (2010) Doença Aguda de Chagas. Revista de Patologia Tropical / Journal of Tropical Pathology, v. 36, n. 3, 4.
De Faria CR, Melo-Sousa SE, Rassi A. (1982) Estudo neurofisiológico na doença de Chagas. Rev Goiana Med. v.28(1/2):3-21.
DeFaria, C. R., Rezende, J. M. D., & Rassi, A. (1988). Desnervação periférica nas diferentes formas clínicas da doença de Chagas. Arquivos de Neuro-Psiquiatria, 46(3), 225-237.
Dias, J. S., Lacerda, A. M., Vieira-de-Melo, R. M., Viana, L. C., Jesus, P. A., Reis, F. J., Nitrini, R., Charcat-Fichman, H, Lopes A. A. & Oliveira-Filho, J. (2009). Cognitive dysfunction in chronic Chagas disease cardiomyopathy. Dementia & neuropsychologia, 3(1), 27-33.
Filley, C. M. (2012). White matter dementia. Therapeutic advances in neurological disorders, 5(5), 267-277.
Filley, C. M., Franklin, G. M., Heaton, R. K., & Rosenberg, N. L. (1988). White matter dementia: clinical disorders and implications. Neuropsychiatry, Neuropsychology, & Behavioral Neurology.
Franklin, G. M., Nelson, L. M., Filley, C. M., & Heaton, R. K. (1989). Cognitive loss in multiple sclerosis: case reports and review of the literature. Archives of Neurology, 46(2), 162-167.
Jorg, M. E., & Zalazar Rovira, I. (1981). Formas encefalopaticas de enfermedad de Chagas cronica observadas en Argentina. Memórias do Instituto Oswaldo Cruz, 76(4), 353-360.
Genovese, O. M., Sanz, O. P., Correale, J., Erro, M. G., & Sica, R. E. P. (1989). Cerebral evoked potentials in human chronic Chagas' disease. Arquivos de neuro-psiquiatria, 47(3), 274-278.
Goin, J. C., Borda, E. S., Auger, S., Storino, R., & Sterin-Borda, L. (1999). Cardiac M2 muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia. Heart, 82(3), 273-278.
Guimarães, P. M., Passos, S. R., Calvet, G. A., Hökerberg, Y. H., Lessa, J. L., & Andrade, C. A. D. (2014). Suicide risk and alcohol and drug abuse in outpatients with HIV infection and Chagas disease. Brazilian Journal of Psychiatry, 36(2), 131-137.
Hagui, A., Souza, S.M., Lopes, D. S., Rodrigues, F.V. (2019) Assimetrias da atenção visuoespacial em idosos. Ciências & Cognição, 24(1), 015-024.
Lai, M. K. P., Lai, O. F., Keene, J., Esiri, M. M., Francis, P. T., Hope, T., & Chen, C. H. (2001). Psychosis of Alzheimer’s disease is associated with elevated muscarinic M2 binding in the cortex. Neurology, 57(5), 805-811.
Lima-Costa, M. F., Castro-Costa, E., Uchôa, E., Firmo, J., Ribeiro, A. L. P., Ferri, C. P., & Prince, M. (2009). A population-based study of the association between Trypanosoma cruzi infection and cognitive impairment in old age (the Bambuí Study). Neuroepidemiology, 32(2), 122-128.
Macedo, V., Prata, A., Silva, G. R., & Castillo, E. (1982). Prevalência de alterações eletrocardiográficas em chagásicos (Informações preliminares sobre o Inquérito Eletrocardiográfico Nacional). Arq. bras. cardiol, 261-4.
Maheut-Bosser, A., Brembilla-Perrot, B., Hanesse, B., Piffer, I., & Paille, F. (2006, October). Troubles cognitifs chez les sujets de plus de 65 ans induits par la prise de digoxine. In Annales de cardiologie et d'angeiologie (Vol. 55, No. 5, pp. 246-248). Elsevier Masson.
Mangone, C. A., Sica, R. E. P., Pereyra, S., Genovese, O., Segura, E., Riarte, A., ... & Segura, M. (1994). Cognitive impairment in human chronic Chagas' disease. Arquivos de neuro-psiquiatria, 52(2), 200-203.
Oliveira-Filho, J. (2009). Stroke and brain atrophy in chronic Chagas disease patients: a new theory proposition. Dementia & neuropsychologia, 3(1), 22-26.
Pan American Health Organization. (2017) Neglected infectious diseases. Chagas Disease [web log post]. Recuperado de https://www.paho.org/en/topics/chagas-disease.
Pereira, G. V. (2016). Alterações neurológicas e comportamentais (ansiedade, depressão e memória) na fase crônica da infecção pelo Trypanosoma cruzi: modelo experimental e propostas terapêuticas (Doctoral dissertation).
Pitella, J. E. H. (1984). Ischemic cerebral changes in the chronic chagasic cardiopathy. Arquivos de neuro-psiquiatria, 42(2), 105-115.
Prost, Julio Oscar, Romero Villanueva, Horacio, Morikone, Ana María, Polo, Gustavo, & Bosch, Ana María. (2000). Evidências de compromiso cerebral en el estadio crónico de la enfermedad de Chagas obtenidas por medio del potencial P300 y de electroencefalografía cuantificada. Arquivos de Neuro-Psiquiatria, 58(2A), 262-271.
Ribeiro, A. L. P., de Carvalho, A. C. C., Teixeira, M. M., Lombardi, F., & Rocha, M. O. C. (2008). Chagas disease: impaired vagal modulation has been demonstrated, enhanced parasympathetic activity remains to be proved. International Journal of Cardiology, 123(3), 330-332.
Sacco, R. L. (1997). Risk factors, outcomes, and stroke subtypes for ischemic stroke. Neurology, 49(5 Suppl 4), S39-S44.
Said, G., Joskowicz, M., Barreira, A. A., & Eisen, H. (1985). Neuropathy associated with experimental Chagas' disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 18(6), 676-683.
Selnes, O. A., & Vinters, H. V. (2006). Vascular cognitive impairment. Nature clinical practice neurology, 2(10), 538-547.
Silva, R. R. (2015) Efeitos de IFN3B3 e TNF sobre a infecção de astrócitos pelo Trypanosoma cruzi. Tese (Doutorado em Biologia Parasitária) - Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de janeiro, RJ.
Villalta, F., Dobish, M. C., Nde, P. N., Kleshchenko, Y. Y., Hargrove, T. Y., Johnson, C. A., ... & Lepesheva, G. I. (2013). VNI cures acute and chronic experimental Chagas disease. The Journal of infectious diseases, 208(3), 504-511.
Vogels, R. L., Scheltens, P., Schroeder‐Tanka, J. M., & Weinstein, H. C. (2007). Cognitive impairment in heart failure: a systematic review of the literature. European journal of heart failure, 9(5), 440-449.
Wackermann, P. V., Fernandes, R. M. F., Elias Jr, J., Dos Santos, A. C., Marques Jr, W., & Barreira, A. A. (2008). Involvement of the central nervous system in the chronic form of Chagas' disease. Journal of the neurological sciences, 269(1-2), 152-157.
Zuchner, T., Schliebs, R., & Perez‐Polo, J. R. (2005). Down‐regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease‐relevant genes and proteins. Journal of neurochemistry, 95(1), 20-32.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Natalia Ligabô dos Santos; Laysa Rodrigues dos Reis; Felipe Viegas Rodrigues

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.